Cellebrite DI Ltd. (CLBT) Shareholder Equity
- 2025-12-31: Additional Paid in CapitalUSD $568.72M; Treasury Stock, ValueUSD $85.00K; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.22M; Retained Earnings (Accumulated Deficit)USD $-86.54M.
- 2025-06-30: Additional Paid in CapitalUSD $533.85M; Treasury Stock, ValueUSD $85.00K; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.64M; Retained Earnings (Accumulated Deficit)USD $-127.99M.
- 2024-12-31: Additional Paid in CapitalUSD $498.88M; Treasury Stock, ValueUSD $85.00K; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $2.09M; Retained Earnings (Accumulated Deficit)USD $-164.86M.
- 2024-06-30: Additional Paid in CapitalUSD $-64.28M; Treasury Stock, ValueUSD $85.00K; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.25M; Retained Earnings (Accumulated Deficit)USD $22.96M.
Cellebrite DI Ltd. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Common Stock, Value, Outstanding USD | Treasury Stock, Common, Shares shares | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Common Stock, Value, Issued USD | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Retired, Par Value Method, Amount USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Treasury Stock, Shares, Acquired shares | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $568.72M | $85.00K | $2.22M | $-86.54M | $484.32M | $0.00 | 41.78K | (m) | 12 month · $44.89M | 12 month · $-3.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $533.85M | $85.00K | $2.64M | $-127.99M | $408.41M | (m) | 41.78K | 6 month · $17.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $498.88M | $85.00K | $2.09M | $-164.86M | $336.02M | $0.00 | 41.78K | (m) | 12 month · $30.57M | 12 month · $-315.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $-64.28M | $85.00K | $1.25M | $22.96M | $-40.16M | (m) | 41.78K | 6 month · $12.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $-84.90M | $85.00K | $1.05M | $118.14M | $34.21M | $0.00 | 41.78K | (m) | 12 month · $19.00M | 12 month · $1.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $-108.17M | $85.00K | $-483.00K | $126.29M | $17.56M | (m) | 41.78K | 6 month · $9.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-125.62M | $85.00K | $331.00K | $199.24M | $73.86M | $0.00 | 41.78K | (m) | 12 month · $13.71M | (m) | (m) | (m) | (m) | (m) | (m) | 41.78K |
| 2022-06-30 | $-141.92M | $85.00K | $-1.01M | $167.07M | $24.06M | (m) | (m) | (m) | 6 month · $6.46M | (m) | $10.00K | (m) | (m) | (m) | (m) | 41.78K |
| 2021-12-31 | $-153.07M | $85.00K | $1.37M | $78.44M | $-73.35M | $0.00 | (m) | (m) | 12 month · $6.48M | (m) | $0.00 | (m) | (m) | 12 month · $4.87M | (m) | 41.78K |
| 2021-06-30 | (m) | (m) | (m) | (m) | $77.57M | (m) | (m) | (m) | 6 month · $3.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $34.23M | $85.00K | $1.32M | $28.34M | $63.80M | (m) | (m) | (m) | 12 month · $7.27M | (m) | $0.00 | 12 month · $85.00K | (m) | (m) | 12 month · 41.78K | 43.54K |
| 2019-12-31 | (m) | (m) | (m) | (m) | $58.83M | (m) | (m) | (m) | 12 month · $12.76M | (m) | (m) | 12 month · $808.00K | 12 month · $0.00 | (m) | 12 month · 295.00K | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $69.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |